ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 110 filers reported holding ERASCA INC in Q3 2023. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,751,109 | -28.6% | 888,888 | 0.0% | 1.90% | -4.3% |
Q2 2023 | $2,453,331 | -8.3% | 888,888 | 0.0% | 1.98% | -33.8% |
Q1 2023 | $2,675,553 | -30.2% | 888,888 | 0.0% | 3.00% | -38.6% |
Q4 2022 | $3,831,107 | -44.7% | 888,888 | 0.0% | 4.88% | -33.2% |
Q3 2022 | $6,933,000 | +40.0% | 888,888 | 0.0% | 7.30% | +59.0% |
Q2 2022 | $4,951,000 | -35.2% | 888,888 | 0.0% | 4.59% | -9.8% |
Q1 2022 | $7,644,000 | -44.8% | 888,888 | 0.0% | 5.09% | -32.3% |
Q4 2021 | $13,849,000 | – | 888,888 | – | 7.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AH Equity Partners Bio II, L.L.C. | 2,500,000 | $19,500,000 | 13.59% |
ARCH Venture Management, LLC | 11,055,554 | $86,233,000 | 11.18% |
EDBI Pte Ltd | 888,888 | $6,933,000 | 7.30% |
Cormorant Asset Management, LP | 10,505,554 | $81,943,000 | 5.73% |
AH Equity Partners V, L.L.C. | 50,000 | $390,000 | 2.53% |
AH Equity Partners LSV II, L.L.C. | 312,500 | $2,438,000 | 2.18% |
PFM Health Sciences, LP | 7,264,981 | $56,667,000 | 2.05% |
Artal Group S.A. | 3,172,221 | $24,743,000 | 1.06% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 472,472 | $3,685,000 | 0.75% |
EcoR1 Capital, LLC | 678,441 | $5,292,000 | 0.16% |